Claims for Patent: 11,154,552

Summary for Patent: 11,154,552

Title:	Aripiprazole prodrug composition
Abstract:	Described is a composition comprising (a) a population of particles of an aripiprazole prodrug having a volume based particle size (Dv50) of less than 1000 nm and (b) at least one surface stabilizer comprising an adsorbed component which is adsorbed on the surface of the aripiprazole prodrug particles and a free component available for solubilisation of the aripiprazole prodrug. The surface stabilizer to prodrug ratio provides the optimal quantity of free surface stabilizer for the purposes of producing a lead-in formulation. Also described are methods of treatment using the aforementioned composition.
Inventor(s):	Cresswell; Philip (Athlone, IE), Hickey; Magali (Westwood, MA), Perkin; Kristopher (Athlone, IE), Smith; Greg (Norton, MA), Liversidge; Elaine (Charlestown, MA), Steinberg; Brian (Arlington, MA), Manser; David (Keenagh, IE), Zeidan; Tarek (Waltham, MA)
Assignee:	ALKERMES PHARMA IRELAND LIMITED (Dublin, IE)
Application Number:	16/904,246
Patent Claims:	1. A composition comprising: (a) a population of particles of an aripiprazole prodrug having a volume based particle size (Dv50) of between about 350 nm and about 175 nm as determined by light scattering techniques, (b) at least one surface stabilizer comprising an adsorbed component which is adsorbed on the surface of the aripiprazole prodrug particles and a free component available for solubilisation of the aripiprazole prodrug, wherein the ratio of aripiprazole prodrug to surface stabilizer is between about 14:1 and about 22:1, and wherein the aripiprazole prodrug has the formula: ##STR00005## and wherein the at least one surface stabilizer is polysorbate 20. 2. A composition comprising polysorbate 20, a chelating agent, a tonicity agent, an aqueous buffer, and a population of particles of the formula: ##STR00006## having a volume based particle distribution size (Dv50) between about 350 nm and about 175 nm as determined by light scattering techniques, wherein the ratio of said particles to polysorbate 20 is about 14:1 to about 22:1. 3. A composition comprising polysorbate 20, a chelating agent, a tonicity agent, an aqueous buffer, and a population of particles of the formula: ##STR00007## having a volume based particle distribution size (Dv50) less than about 350 nm as determined by light scattering techniques, wherein the ratio of said particles to polysorbate 20 is about 14:1 to about 22:1. 4. A composition comprising polysorbate 20 and a population of particles of the formula: ##STR00008## having a volume based particle distribution size (Dv50) less than about 350 nm as determined by light scattering techniques, wherein the ratio of said particles to polysorbate 20 is about 14:1 to about 22:1. 5. The composition of claim 1, wherein the ratio of said particles to polysorbate 20 is about 17:1 to about 20:1. 6. The composition of claim 1, wherein the ratio of said particles to polysorbate 20 is about 17:1. 7. The composition of claim 2, wherein the ratio of said particles to polysorbate 20 is about 17:1 to about 20:1. 8. The composition of claim 2, wherein the ratio of said particles to polysorbate 20 is about 17:1. 9. The composition of claim 3, wherein the ratio of said particles to polysorbate 20 is about 17:1 to about 20:1. 10. The composition of claim 3, wherein the ratio of said particles to polysorbate 20 is about 17:1. 11. The composition of claim 4, wherein the ratio of said particles to polysorbate 20 is about 17:1 to about 20:1. 12. The composition of claim 4, wherein the ratio of said particles to polysorbate 20 is about 17:1.